Abernethy A, Abrahams E, Barker A, Buetow K, Burkholder R, Dalton WS, Foti M, Frueh F, Gaynor RB, Kean M, Khan Z, Lessor T, Lichtenfeld JL, Mendelsohn J, van't Veer L. Turning the Tide Against Cancer Through Sustained Medical Innovation: The Pathway to Success. Clin Cancer Res (2014).
Chen QR, Hu Y, Yan C, Buetow K, Meerzaman D. Systematic Genetic Analysis Identifies Cis-eQTL Target Genes Associated with Glioblastoma Patient Survival. PLoS One (0).
Meerzaman DM, Yan C, Edmonson MN, Schaefer CF, Clifford RJ, Dunn BK, Dong L, Finney RP, Cultraro CM, Hu Y, Yang Z, Nguyen CV, Kelley JM, Cai S, Zhang H, Zhang J, Wilson R, Messmer L, Chen QR, Chung YH, Kim JA, Park NH, Lyu MS, Song IH, Buetow KH. Genome-wide transcriptional sequencing identifies novel mutations in metabolic genes in human hepatocellular carcinoma (HCC). Cancer Genomics Proteomics (0).
Nicolasjilwan M, Hu Y, Yan C, Meerzaman D, Holder CA, Gutman D, Jain R, Colen R, Rubin DL, Zinn PO, Hwang SN, Raghavan P, Hammoud DA, Scarpace LM, Mikkelsen T, Chen J, Gevaert O, Buetow K, Freymann J, Kirby J, Flanders AE, Wintermark M;. Addition of MR Imaging Features and Genetic Biomarkers Strengthens Glioblastoma Survival Prediction in TCGA Patients. J Neuroradiol (0).
Research Activity
Buetow,Kenneth H*. Phase II: A Multiple Sclerosis Patient-Powered Research Network. ACP(9/5/2015 - 9/4/2018).
Buetow,Kenneth H*. A Multiple Sclerosis Patient-Powered Research Network. ACP(3/1/2014 - 11/30/2015).
Buetow,Kenneth H*. Immune Simulator for in silico research relevant to immune-based oncology drug targets. BRISTOL-MYERS-SQUIBB CO(12/3/2013 - 12/2/2016).
